Surgery for Pancreatic Cancer.

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Surgical resection is the sole potentially curative treatment for pancreatic cancer.
• High rates of systemic recurrence and limited surgical candidacy due to local invasion or distant spread are significant challenges.
• Pancreatic surgery, while having low perioperative mortality in high-volume centers, is associated with substantial morbidity.

Purpose of the Study:

• To review the current role and evolving strategies in surgical resection for pancreatic cancer.
• To discuss the application of minimally invasive and robotic techniques in pancreatic surgery.
• To explore methods for extending the benefits of margin-negative resection to a broader patient population.

Main Methods:

• Review of current surgical practices and outcomes in pancreatic cancer.
• Discussion of advanced surgical techniques, including minimally invasive and robotic approaches.
• Analysis of neoadjuvant therapy and extended resection strategies for locally advanced disease.

Main Results:

• Surgical resection is limited to a minority of patients due to disease extent.
• Minimally invasive and robotic techniques are increasingly adopted but not universally applicable.
• Extended resections and neoadjuvant therapy are strategies to improve resectability and outcomes.

Conclusions:

• Surgical resection remains critical for potentially curative treatment of pancreatic cancer.
• Overcoming challenges requires innovative approaches like neoadjuvant therapy and complex surgical reconstructions.
• Expanding surgical candidacy and improving outcomes necessitates continued advancements in surgical techniques and multimodal treatment strategies.